The sustainability of this phenotype is a result in part of activation of the transcription factor signal transducer and activator of transcription 3 (STAT3).5 Furthermore, other transcription factors and proteins have been identified as potential triggers of vascular dysfunctions and PA remodeling in PAH. The gene discussed is STAT3; the disease is pulmonary arterial hypertension.